Loading company…
ID 404388783 · FY 2018–2024 · 7 years
Subsidiary of შეზღუდული პასუხისმგებლობისსაზოგადოება ფილუეტ საიპრეს ლიმიტედ (100.0%)
კომპანიის ძირითადი საქმიანობაა სხვადასხვა ბიოლოგიურად აქტიური საკვები დანამატების და თავის მოვლის საშუალებების იმპორტი და რეალიზაცია.
Bars are revenue on the left axis; lines are EBITDA and net margin on the right.
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|---|---|---|---|
| Net Cash from Operating Activities | 1,487 | 2,305 | 1,995 | 1,234 | 2,085 | -73 | -1,066 | nmf |
| Net Cash used in Investing Activities | -9 | -25 | -37 | -728 | -5 | -150 | -61 | +36.5% |
| Free Cash Flow (OCF − Capex proxy) | 1,478 | 2,280 | 1,958 | 506 | 2,080 | -224 | -1,127 | nmf |
| Net Cash from Financing Activities | -1,065 | -1,322 | -2,729 | -1,471 | -1,975 | 224 | 1,186 | nmf |
| Net Change in Cash (before FX) | 413 | 958 | -770 | -965 | 104 | 1 | 59 | -27.7% |
| Effect of FX on Cash | -129 | -339 | 314 | -357 | -5 | -33 | -92 | -5.5% |
| Net Change in Cash (incl. FX) | 283 | 619 | -456 | -1,322 | 99 | -32 | -33 | nmf |
| Cash at Beginning of Year | 1,056 | 1,340 | 1,959 | 1,503 | 181 | 280 | 248 | -21.5% |
| Cash at End of Year | 1,340 | 1,959 | 1,503 | 181 | 280 | 248 | 215 | -26.3% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Companies sharing this sub-sector, ranked by how close their latest revenue is to this one — not a curated comp set.
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
Dividends declared (per SOCE filings): FY2022 ₾1.7m · FY2023 ₾0 · FY2024 ₾0 — 3-yr total ₾1.7m
Ownership & directors from companyinfo.ge (public corporate registry).